Cite
HARVARD Citation
Arkenau, H. et al. (2018). Ramucirumab Plus Pembrolizumab in Patients with Previously Treated Advanced or Metastatic Biliary Tract Cancer: Nonrandomized, Open‐Label, Phase I Trial (JVDF). Oncologist. pp. 1407-e136. [Online].